Pharmaceutical business intelligence group Cutting Edge Information has launched a new report, Managed Markets 2007: Pharmaceutical Reimbursement Strategy, Organizational Structure and Medicare Part D.
Gleaned from interviews and surveys with managed markets marketing and account management executives in the pharmaceutical and biotechnology industries, the report assesses drug companies' managed health care departmental structure, spending and staffing levels; organizational models at firms of all sizes; account alignment strategies; Medicare Part D's impact on managed markets organizations; and reimbursement strategies.
With the burgeoning role that market access plays in products' commercial performance, companies are expanding their departments to enhance product messaging and expand their reach to more managed care, federal and state government; trade; long-term care; and pharmacy benefit management accounts, says the report.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze